Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment.

ABSTRACT: Nanotechnology has increasingly emerged as a promising tool for exploring new approaches, from treating complex conditions to early detection of the onset of multiple disease states. Tailored designer nanoparticles can now more comprehensively interact with their cellular targets and various pathogens due to a similar size range and tunable surface properties. The basic goal of drug delivery is to employ pharmaceuticals only where they are needed, with as few adverse effects and off-target consequences as possible. Rheumatoid arthritis (RA) is a chronic inflammatory illness that leads to progressive loss of bone and cartilage, resulting in acute impairment, decreased life expectancy, and increased death rates. Recent advancements in treatment have significantly slowed the progression of th

SUBMITTER: Nasra S 

PROVIDER: S-EPMC9400644 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature